Pfizer said on Monday that its two-dose COVID vaccine works for children ages 5 to 11 and that it plans to seek authorization from regulatory agencies as soon as possible.

If the regulatory review goes smoothly, young kids could start rolling up their sleeves relatively soon. What does that mean…